Humira pen 40 MG/0.8 MLS
Ended Awarded
- Contract number
- SPE2DB25FJLGY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,434
Award facts
- Contract value 100% obligated
- $2,433.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,433.72 to DMS Pharmaceutical Group Inc. for HUMIRA Pen 40 mg/0.8 mL units on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. HUMIRA (adalimumab) is a widely-used biologic medication primarily prescribed for treating rheumatoid arthritis, psoriasis, and other autoimmune conditions, supporting the pharmaceutical supply needs of Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler established in 2001, has established itself as a critical supplier within the federal pharmaceutical supply chain, regularly delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's ability to secure this award demonstrates its continued capacity to provide specialized pharmaceutical products essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FJLGY?
SPE2DB25FJLGY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FJLGY worth?
The government has obligated $2,434 on SPE2DB25FJLGY.
Is contract SPE2DB25FJLGY an order under another contract?
Yes. SPE2DB25FJLGY is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLGY competed?
The extent of competition for SPE2DB25FJLGY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award